People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Healthtech, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Koda Health, Inc. | — | Healthtech | Series A | $12.2M | $39.3M | 2025 |
| Epistemix, Inc. | — | Other Technology | Series A | $11.7M | $30.3M | 2022 |
| Threatwarrior Inc. | — | Other Technology | Series A | $11.6M | $173.6M | 2021 |
| Nanotech, Inc. | — | Other | Series A | $9.3M | $56.5M | 2023 |
Adam Lipman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adam Lipman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Sean Glass | 1 | 4 |
| Benjamin Dahl | 1 | 4 |
| Stephen Remondi | 1 | 3 |
| ROBERT DELACH | 1 | 2 |
| Tatiana Fofanova | 1 | 1 |
| Desh Mohan | 1 | 1 |
| John Cordier | 1 | 1 |
| Daniel Litvak | 1 | 1 |
| John Greffenstette | 1 | 1 |
| Donald Burke | 1 | 1 |
| John Grefenstette | 1 | 1 |
| Claudinei Calado | 1 | 1 |
| Mike Francis | 1 | 1 |
| Hani Taan | 1 | 1 |
| Jonathan Bumba | 1 | 1 |
| Lisa Shasteen | 1 | 1 |
| Peter Slade | 1 | 1 |
| Christopher Greendale | 1 | 1 |
| Bruce Coughlin | 1 | 1 |
| Katelin Cherry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.